Report Detail
Global Dengue Vaccine Market Insights, Forecast to 2025
- RnM3492387 |
- 08 July, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.
The global Dengue Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dengue Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Dengue Vaccine in key regions like North America, Europe, China and Japan, focuses on the consumption of Dengue Vaccine in these regions.
This research report categorizes the global Dengue Vaccine market by top players/brands, region, type and end user. This report also studies the global Dengue Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
U.S NIH
Vabiotech
Dengue Vaccine market size by Type
CYD-TDV
DENVax or TAK-003
TetraVax-DV
TDENV PIV
V180
DNA vaccines
Dengue Vaccine market size by Applications
Government Institutions
Hospitals
NGOs
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dengue Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dengue Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dengue Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dengue Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dengue Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dengue Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dengue Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dengue Vaccine Market Size Growth Rate by Type
- 1.4.2 CYD-TDV
- 1.4.3 DENVax or TAK-003
- 1.4.4 TetraVax-DV
- 1.4.5 TDENV PIV
- 1.4.6 V180
- 1.4.7 DNA vaccines
- 1.5 Market by Application
- 1.5.1 Global Dengue Vaccine Market Size Growth Rate by Application
- 1.5.2 Government Institutions
- 1.5.3 Hospitals
- 1.5.4 NGOs
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dengue Vaccine Market Size
- 2.1.1 Global Dengue Vaccine Revenue 2014-2025
- 2.1.2 Global Dengue Vaccine Sales 2014-2025
- 2.2 Dengue Vaccine Growth Rate by Regions
- 2.2.1 Global Dengue Vaccine Sales by Regions
- 2.2.2 Global Dengue Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dengue Vaccine Sales by Manufacturers
- 3.1.1 Dengue Vaccine Sales by Manufacturers
- 3.1.2 Dengue Vaccine Sales Market Share by Manufacturers
- 3.2 Dengue Vaccine Revenue by Manufacturers
- 3.2.1 Dengue Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Dengue Vaccine Price by Manufacturers
- 3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dengue Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Dengue Vaccine Sales by Type
- 4.2 Global Dengue Vaccine Revenue by Type
- 4.3 Dengue Vaccine Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Dengue Vaccine Breakdown Data by Application
6 North America
- 6.1 North America Dengue Vaccine by Country
- 6.1.1 North America Dengue Vaccine Sales by Country
- 6.1.2 North America Dengue Vaccine Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dengue Vaccine by Type
- 6.3 North America Dengue Vaccine by Application
7 Europe
- 7.1 Europe Dengue Vaccine by Country
- 7.1.1 Europe Dengue Vaccine Sales by Country
- 7.1.2 Europe Dengue Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dengue Vaccine by Type
- 7.3 Europe Dengue Vaccine by Application
8 Asia Pacific
- 8.1 Asia Pacific Dengue Vaccine by Region
- 8.1.1 Asia Pacific Dengue Vaccine Sales by Region
- 8.1.2 Asia Pacific Dengue Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Thailand
- 8.1.10 Malaysia
- 8.1.11 Philippines
- 8.1.12 Vietnam
- 8.2 Asia Pacific Dengue Vaccine by Type
- 8.3 Asia Pacific Dengue Vaccine by Application
9 Central & South America
- 9.1 Central & South America Dengue Vaccine by Country
- 9.1.1 Central & South America Dengue Vaccine Sales by Country
- 9.1.2 Central & South America Dengue Vaccine Revenue by Country
- 9.1.3 Brazil
- 9.2 Central & South America Dengue Vaccine by Type
- 9.3 Central & South America Dengue Vaccine by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Dengue Vaccine by Country
- 10.1.1 Middle East and Africa Dengue Vaccine Sales by Country
- 10.1.2 Middle East and Africa Dengue Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 GCC Countries
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dengue Vaccine by Type
- 10.3 Middle East and Africa Dengue Vaccine by Application
11 Company Profiles
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GlaxoSmithKline Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
- 11.1.5 GlaxoSmithKline Recent Development
- 11.2 Merck Sharp & Dohme
- 11.2.1 Merck Sharp & Dohme Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck Sharp & Dohme Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck Sharp & Dohme Dengue Vaccine Products Offered
- 11.2.5 Merck Sharp & Dohme Recent Development
- 11.3 Sanofi
- 11.3.1 Sanofi Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi Dengue Vaccine Products Offered
- 11.3.5 Sanofi Recent Development
- 11.4 Takeda Pharmaceuticals
- 11.4.1 Takeda Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Takeda Pharmaceuticals Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Takeda Pharmaceuticals Dengue Vaccine Products Offered
- 11.4.5 Takeda Pharmaceuticals Recent Development
- 11.5 GeneOne Life Sciences
- 11.5.1 GeneOne Life Sciences Company Details
- 11.5.2 Company Business Overview
- 11.5.3 GeneOne Life Sciences Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 GeneOne Life Sciences Dengue Vaccine Products Offered
- 11.5.5 GeneOne Life Sciences Recent Development
- 11.6 Medigen Biologics
- 11.6.1 Medigen Biologics Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Medigen Biologics Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Medigen Biologics Dengue Vaccine Products Offered
- 11.6.5 Medigen Biologics Recent Development
- 11.7 Panacea Biotec
- 11.7.1 Panacea Biotec Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Panacea Biotec Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Panacea Biotec Dengue Vaccine Products Offered
- 11.7.5 Panacea Biotec Recent Development
- 11.8 Sun Pharmaceutical
- 11.8.1 Sun Pharmaceutical Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Sun Pharmaceutical Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Sun Pharmaceutical Dengue Vaccine Products Offered
- 11.8.5 Sun Pharmaceutical Recent Development
- 11.9 U.S NIH
- 11.9.1 U.S NIH Company Details
- 11.9.2 Company Business Overview
- 11.9.3 U.S NIH Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 U.S NIH Dengue Vaccine Products Offered
- 11.9.5 U.S NIH Recent Development
- 11.10 Vabiotech
- 11.10.1 Vabiotech Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Vabiotech Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Vabiotech Dengue Vaccine Products Offered
- 11.10.5 Vabiotech Recent Development
12 Future Forecast
- 12.1 Dengue Vaccine Market Forecast by Regions
- 12.1.1 Global Dengue Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dengue Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Dengue Vaccine Market Forecast by Type
- 12.2.1 Global Dengue Vaccine Sales Forecast by Type 2019-2025
- 12.2.2 Global Dengue Vaccine Revenue Forecast by Type 2019-2025
- 12.3 Dengue Vaccine Market Forecast by Application
- 12.4 North America Dengue Vaccine Forecast
- 12.5 Europe Dengue Vaccine Forecast
- 12.6 Asia Pacific Dengue Vaccine Forecast
- 12.7 Central & South America Dengue Vaccine Forecast
- 12.8 Middle East and Africa Dengue Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dengue Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dengue Vaccine . Industry analysis & Market Report on Dengue Vaccine is a syndicated market report, published as Global Dengue Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dengue Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
